Pricing Log in Create free account

Artelo Biosciences, Inc. (ARTL) vs Bone Biologics Corp. (BBLG)

Artelo Biosciences, Inc. and Bone Biologics Corp. are both Biotechnology companies. Artelo Biosciences, Inc. and Bone Biologics Corp. are of similar size ($1.2M and $1.1M). Across the 9 metrics below, Bone Biologics Corp. leads on 7 and Artelo Biosciences, Inc. on 2.

Valuation

Metric ARTL BBLG Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.12 0.20 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.33 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (10,336.94%) (438.22%) (32.88%)
Free cash flow yield (2,139.52%) (214.89%) (23.13%)

Profitability

Metric ARTL BBLG Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (705.71%) (47.49%) (51.96%)
Return on assets (234.30%) (44.46%) (46.06%)
Return on invested capital (865.85%) 0.00% 0.00%

Growth

Metric ARTL BBLG Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 31.57% 90.85% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARTL BBLG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.00 13.38 4.97
Net debt to EBITDA 0.05 1.65 1.01

Dividend

Metric ARTL BBLG Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARTL BBLG Biotechnology median
Market cap 1.16m 1.10m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack